Relationship of health-related social needs and hospital readmissions in patients following a hospitalization for atrial fibrillation.

Atrial fibrillation Readmission Sex differences Social determinants of health

Journal

American heart journal plus : cardiology research and practice
ISSN: 2666-6022
Titre abrégé: Am Heart J Plus
Pays: United States
ID NLM: 101779333

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 12 07 2023
revised: 20 10 2023
accepted: 22 10 2023
medline: 21 3 2024
pubmed: 21 3 2024
entrez: 21 3 2024
Statut: epublish

Résumé

Atrial fibrillation (AF) has a high economic burden on the healthcare system with rehospitalizations as the most significant contributing factor necessitating an understanding of aspects related to hospitalizations to minimize economic costs and improve patient outcomes. Our study aims to assess whether all-cause 30-day hospital readmission following AF-specific hospitalization is associated with health-related social needs (HRSN) using the Nationwide Readmissions Database (NRD). All hospitalization data were abstracted from the 2015-2019 NRD, including hospitalizations for patients at least 18 years of age with a primary discharge diagnosis of AF. For each hospitalization, we identified secondary diagnoses for five HRSN domains including employment, family, housing, psychosocial, and socioeconomic status. Primary outcomes included all-cause 30-day readmission rates. Secondary outcomes included all-cause 90-day readmissions and diagnosis on readmissions. An estimated 1,807,460 index hospitalizations in the United States included a primary discharge diagnosis of AF. Of these, 97.3 % included a diagnosis in only one HRSN domain with the most frequently diagnosed HRSN domain being housing (54.5 %) followed by socioeconomic (29.4 %), family (10.0 %), employment (6.1 %), and psychosocial (2.8 %). Index hospitalizations that included any HRSN diagnosis had 2.2-times greater unadjusted odds of all-cause 30-day readmission (95 % CI: 2.1 to 2.3-times greater,

Identifiants

pubmed: 38510101
doi: 10.1016/j.ahjo.2023.100340
pii: S2666-6022(23)00093-9
pmc: PMC10946007
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100340

Informations de copyright

© 2023 The Authors.

Déclaration de conflit d'intérêts

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Michael H. Kim, MD, MMM reports a relationship with Sanofi that includes: consulting or advisory.

Auteurs

Azka Latif (A)

Department of Cardiovascular Medicine, Baylor College of Medicine, Houston, TX, United States of America.

Amy M Tran (AM)

School of Medicine, Creighton University, Omaha, NE, United States of America.

Muhammad Junaid Ahsan (MJ)

Division of Cardiovascular Medicine, Iowa Heart Center, West Des Moines, IA, United States of America.

Fang Niu (F)

Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE, United States of America.

Ryan W Walters (RW)

Department of Clinical Research and Public Health, Creighton University, Omaha, NE, United States of America.

Michael H Kim (MH)

Department of Medicine, Creighton University and CHI Health, Omaha, NE, United States of America.

Classifications MeSH